APA (7th ed.) Citation

Todenhöfer, T., Hennenlotter, J., Leidenberger, P., Wald, A., Hohneder, A., Kühs, U., . . . Schwentner, C. (2014). Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. BJU international, 113(1), 152-159. https://doi.org/10.1111/j.1464-410X.2012.11759.x

Chicago Style (17th ed.) Citation

Todenhöfer, Tilman, et al. "Serum Receptor Activator of Nuclear Factor κB Ligand (RANKL) Levels Predict Biochemical Recurrence in Patients Undergoing Radical Prostatectomy." BJU International 113, no. 1 (2014): 152-159. https://doi.org/10.1111/j.1464-410X.2012.11759.x.

MLA (9th ed.) Citation

Todenhöfer, Tilman, et al. "Serum Receptor Activator of Nuclear Factor κB Ligand (RANKL) Levels Predict Biochemical Recurrence in Patients Undergoing Radical Prostatectomy." BJU International, vol. 113, no. 1, 2014, pp. 152-159, https://doi.org/10.1111/j.1464-410X.2012.11759.x.